These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 4810604)

  • 1. Fate of murine fibrosarcoma allografts and radiolabeled tumor-enhancing IgG2, normal (nonenhancing) IgG2 and bacterial endotoxin in endotoxin-tolerant and nontolerant mice.
    Cruse JM; Lewis GK; Whitten HD; Watson ES; Fields JF; Adams ST; Harvey GF; Paslay JW; Baldwin J; Porter M
    J Reticuloendothel Soc; 1974 Jan; 15(1):75-84. PubMed ID: 4810604
    [No Abstract]   [Full Text] [Related]  

  • 2. A synergistic immunosuppressive effect of endotoxin and PHA-M on immunologic enhancement in mice.
    Cruse JM; Forbes JT; Shivers BR; Gillespie GY; Lewis GK; Scales RW; Fields JF; Hester RB; Watson ES; Whitten HD
    Z Immunitatsforsch Exp Klin Immunol; 1972 Jan; 143(1):31-42. PubMed ID: 4282905
    [No Abstract]   [Full Text] [Related]  

  • 3. Antigen driven selection for Fc receptors of enhancing antibody on macrophages during an alloimmune response.
    Whitten HD; Cruse JM; Lewis GK; Watson ES
    J Reticuloendothel Soc; 1974 Feb; 15(2):118-25. PubMed ID: 4815211
    [No Abstract]   [Full Text] [Related]  

  • 4. Facilitation of macrophage-mediated destruction of allogeneic fibrosarcoma cells by tumor-enhancing IgG 2 in vitro.
    Cruse JM; Whitten HD; Lewis GK; Watson ES
    Transplant Proc; 1973 Mar; 5(1):961-7. PubMed ID: 4695960
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of tumor-enhancing IgG2 on macrophage function.
    Cruse JM; Lewis R; Dilioglou S
    Exp Mol Pathol; 2004 Aug; 77(1):43-8. PubMed ID: 15215049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet aggregation in rabbits made tolerant to endotoxin.
    Walker RI; Shields LJ; Fletcher JR
    Infect Immun; 1978 Mar; 19(3):919-22. PubMed ID: 346490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of tolerance of the Ia antigen disparate skin allografts.
    Holán V; Hasek M; Chutná J; Holoubková I
    Folia Biol (Praha); 1982; 28(6):395-408. PubMed ID: 6761152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The direct reaction between Salmonella enteritidis endotoxin and antibody. Measurement of 7S and 19S antibody in normal, tolerant and immune sera.
    Gupta JD; Reed CE
    J Immunol; 1967 May; 98(5):1093-103. PubMed ID: 6024982
    [No Abstract]   [Full Text] [Related]  

  • 9. Radiation-induced changes in established tumor immunity.
    Vaage J; Doroshow JH; DuBois TT
    Cancer Res; 1974 Jan; 34(1):129-37. PubMed ID: 4809453
    [No Abstract]   [Full Text] [Related]  

  • 10. Polyclonal B cell activation, endotoxin tolerance, and limulus tests of endotoxin preparations of some periodontopathogens.
    Inada K; Yoshida M; Sasaki O; Suzuki M; Yoshida H; Okuda K; Takazoe I
    Bull Tokyo Dent Coll; 1994 May; 35(2):67-78. PubMed ID: 7987966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible contribution of platelets to the pathophysiology of host responses of endotoxin.
    Walker RI; Fletcher JR
    Prog Clin Biol Res; 1981; 62():173-85. PubMed ID: 7025011
    [No Abstract]   [Full Text] [Related]  

  • 12. The immunogenic activity of tumor antigens retained by the reticuloendothelial cells of tumor-bearing mice.
    Vaage J
    Cancer Res; 1972 May; 32(5):898-903. PubMed ID: 5017740
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of Salm. typhi and its endotoxin on the phagocytic activity of the reticuloendothelial system in mice.
    BIOZZI G; BENACERRAF B; HALPERN BN
    Br J Exp Pathol; 1955 Jun; 36(3):226-35. PubMed ID: 13239977
    [No Abstract]   [Full Text] [Related]  

  • 14. Increased tumour growth after blood transfusion.
    Clarke PJ; Wood KJ; Morris PJ
    Transplant Proc; 1989 Feb; 21(1 Pt 1):584-5. PubMed ID: 2705237
    [No Abstract]   [Full Text] [Related]  

  • 15. Prolonged survival of murine fibrosarcoma allotransplants by anti-enhancing Fab alloantibody.
    Cruse JM; Lewis GK; Whitten HD; Watson ES; Hester RB; Fields JF
    Immunol Commun; 1972; 1(4):367-73. PubMed ID: 4548901
    [No Abstract]   [Full Text] [Related]  

  • 16. Dissection of the immunosuppressive effect of the Fc region of tumor-enhancing IgG.
    Cruse JM; Forbes JT; Gillespie GY; Lewis GK; Scales RW; Shivers BR; Fields JF; Hester RB; Watson ES; Whitten HD
    Z Immunitatsforsch Exp Klin Immunol; 1972 Jan; 143(1):43-58. PubMed ID: 4282906
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term (>1 year) analyses of chimerism and tolerance in mixed allogeneic chimeric mice using normal mouse combinations.
    Hayashi H; Toki J; Zhexiong L; Sugiura K; Inoue K; Ikehara S
    Stem Cells; 2000; 18(4):273-80. PubMed ID: 10924093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endotoxin fails to induce IFN-gamma in endotoxin-tolerant mice: deficiencies in both IL-12 heterodimer production and IL-12 responsiveness.
    Balkhy HH; Heinzel FP
    J Immunol; 1999 Mar; 162(6):3633-8. PubMed ID: 10092824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neither Fas ligand nor endotoxin is responsible for inducible peritoneal phagocyte apoptosis during sepsis/peritonitis.
    Chung CS; Song GY; Moldawer LL; Chaudry IH; Ayala A
    J Surg Res; 2000 Jun; 91(2):147-53. PubMed ID: 10839964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MECHANISMS OF ENDOTOXIN TOLERANCE. II. RELATIONSHIP BETWEEN ENDOTOXIN TOLERANCE AND RETICULOENDOTHELIAL SYSTEM PHAGOCYTIC ACTIVITY IN MAN.
    GREISMAN SE; WAGNER HN; IIO M; HORNICK RB
    J Exp Med; 1964 Feb; 119(2):241-64. PubMed ID: 14164481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.